This section contains information intended for healthcare professionals. Please certify that you are a healthcare professional.

Please indicate your country of residence:

What language is your preference?

  • Sickle cell disease (SCD) is among the most common genetic disorders in the world, affecting over 300,000 newborns annually, with estimates for further increases to over 400,000 annual births within the next generation and with a wider geographical distribution of affected individuals due to global migration.

 

  • Both the World Health Organization (WHO) and the United Nations have identified SCD as a current global health burden
Read the publication

Featured products

See all instruments See all tests

CAPILLARYS 3 DBS

The high throughput solution for screening newborn hemoglobin disorders.

Newborn Hemoglobin disorders screening

The perfect match for screening hemoglobin disorders in newborns.

Learn more about our unique technologies

Capillary Electrophoresis

The worldwide leader in Capillary Electrophoresis with fully automated protein separation at high resolution.

Learn more

Gel Electrophoresis

Comprehensive menu with high-quality results on Agarose gel.

Learn more

This section contains information intended for wide distribution and may therefore contain product details or information that is not available or valid in your country.

Please contact your local Sebia representative. Information intended for healthcare professionals.
Carefully read the instructions in the reagent package inserts and instrument manuals.